内置引流管加尿激酶治疗结核性包裹性胸腔积液60例临床分析  

Clinical Analysis of 60 Cases with the Treatment of Parcel Tuberculous Pleural Effusion by Using Drain and Intrapleral Urokinase

作　　者：任水明[1] 张俊玲[1] 贺连珅[1] 韩勇[1] 

机构地区：[1]鄂尔多斯市中心医院呼吸肾脏内科,内蒙古东胜017000

出　　处：《内蒙古医学杂志》2012年第1期36-38,共3页Inner Mongolia Medical Journal

摘　　要：目的:探讨胸腔内留置深静脉管并注入尿激酶对结核性、包裹性胸腔积液的治疗作用。方法:抗结核治疗下,常规胸腔内留置深静脉管引流胸水,治疗组胸腔内注入尿激酶10万单位+生理盐水10 ml/次,对照组胸腔内只注入生理盐水10ml/次。结果:治疗组总引流量明显优于对照组,遗留胸膜肥厚明显少于对照组,且无并发症发生。结论:内置引流管加尿激酶治疗结核性、包裹性胸腔积液的方法方便,安全,疗效满意,值得在临床上推广应用。Objective：To explore therapeutic effects of parcel tuberculous pleural effusion by using drain and intrapleural urokinase.Methods：The drainage of intravenous guttate was used.The therapy group used UK 100000u plus NS 10 ml/time.The control group used NS 10 ml/time in the thoracic cavity.Regular antituberculosis and prednisone treatment was used for all patients.Results：The therapy group had less pleural incrassation than the control group,but had more drainage quantity than the control group.Neither had the complications.Conclusion：Using drainage in the method of intravenous guttate and intrapleral urokinase on the treatment of parcel tuberculous pleural effusion is a convenient and safe method.It should be recommended for a wider use.

关 键 词：胸腔积液 结核 引流 尿激酶 

分 类 号：R561.3[医药卫生—呼吸系统]